Why is CG Oncology, Inc. ?
1
Flat results in Mar 26
- OPERATING CASH FLOW(Y) Lowest at USD -160.01 MM
- RAW MATERIAL COST(Y) Grown by 437.35% (YoY)
- OPERATING PROFIT(Q) Lowest at USD -65.55 MM
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 173.27%, its profits have fallen by -82.9%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is CG Oncology, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
CG Oncology, Inc.
173.27%
1.73
58.94%
S&P 500
20.86%
1.58
13.23%
Quality key factors
Factor
Value
Sales Growth (5y)
120.00%
EBIT Growth (5y)
-220.02%
EBIT to Interest (avg)
-60.91
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.98
Sales to Capital Employed (avg)
0.00
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
7.25
EV to EBIT
-24.73
EV to EBITDA
-24.92
EV to Capital Employed
328.50
EV to Sales
1167.81
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-1328.32%
ROE (Latest)
-21.39%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Dow Theory
Bullish
Bullish
OBV
Mildly Bearish
No Trend
Technical Movement
14What is working for the Company
NET SALES(HY)
Higher at USD 3.41 MM
NET PROFIT(HY)
Higher at USD -101.51 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 11.08 times
-22What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at USD -160.01 MM
RAW MATERIAL COST(Y)
Grown by 437.35% (YoY
OPERATING PROFIT(Q)
Lowest at USD -65.55 MM
PRE-TAX PROFIT(Q)
Lowest at USD -60.2 MM
NET PROFIT(Q)
Lowest at USD -60.2 MM
EPS(Q)
Lowest at USD -0.71
Here's what is working for CG Oncology, Inc.
Net Sales
At USD 3.41 MM has Grown at 570.28%
Year on Year (YoY)MOJO Watch
Sales trend is very positive
Net Sales (USD MM)
Net Sales
Higher at USD 3.41 MM
than preceding 12 month period ended Mar 2026MOJO Watch
In the half year the company has already crossed sales of the previous twelve months
Net Sales (USD MM)
Inventory Turnover Ratio
Highest at 11.08 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Here's what is not working for CG Oncology, Inc.
Pre-Tax Profit
At USD -60.2 MM has Fallen at -74.74%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -60.2 MM has Fallen at -74.74%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Operating Cash Flow
Lowest at USD -160.01 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Operating Profit
Lowest at USD -65.55 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (USD MM)
Pre-Tax Profit
Lowest at USD -60.2 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Net Profit
Lowest at USD -60.2 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
EPS
Lowest at USD -0.71
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (USD)
Raw Material Cost
Grown by 437.35% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales






